India to suspend sales of drugs banned in other countries

04/28/2013 | Economic Times (India), The

India's health ministry has announced a new policy halting the sale of any drugs banned by the European Union, U.S., U.K., Canada, Japan or Australia. Such sales will be stopped until clinical trials inside India determine that the drugs have no adverse effects on patients. A parliamentary probe last year found that India continued to permit the sale of Analgin, a painkiller banned in Sweden and the U.S., after it was found to trigger a steep decline in white blood cell counts.

View Full Article in:

Economic Times (India), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ